SectorBiological Technology
Established Date26/07/2017
Listing Date28/02/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees60
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressOne Commerce Square
, 2005 Market Street
, 39th Floor
, Philadelphia
, PA 19103
Business
IntroductionPassage Bio, Inc., a Delaware-based company founded on July 26, 2017, is a genetic medicine company focused on the development of translational therapies for rare single-gene central nervous system diseases. Its vision is to become a leading genetic medicine company and actively change the lives of patients whose lives are threatened by these diseases.
